IGM BIOSCIENCES
Dead / Abandoned — Abandoned — no statement of use filed (as of 11 Jul 2022)
What this means for you
This application is over — abandoned 11 Jul 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88484191
- Mark type
- Design + words
- Filed
- 21 Jun 2019
- Published for opposition
- 15 Oct 2019
- Abandoned
- 11 Jul 2022
- Attorney of record
- Karen Feisthamel
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, ophthalmic, neurological, gastrointestinal, hormonal, dermatological, psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
Owner
- IGM Biosciences, Inc., Mountain View, CA, US
- IGM Biosciences, Inc., Mountain View, CA, US
Prosecution history
- 11 Jul 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 11 Jul 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Feb 2022 — CORRECTED NOA E-MAILED
- 03 Feb 2022 — DIVISIONAL PROCESSING COMPLETE
- 10 Dec 2021 — DIVISIONAL REQUEST RECEIVED
- 03 Feb 2022 — SOU EXTENSION 4 GRANTED
- 10 Dec 2021 — SOU EXTENSION 4 FILED
- 27 Jan 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Dec 2021 — NOTICE OF REVIVAL - E-MAILED
- 13 Dec 2021 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 13 Dec 2021 — PETITION TO REVIVE-GRANTED
- 13 Dec 2021 — TEAS PETITION TO REVIVE RECEIVED
- 10 Dec 2021 — TEAS REQUEST TO DIVIDE RECEIVED
- 13 Apr 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED